Adenosine A1 and A3 receptor agonists reduce hypoxic injury through the involvement of P38 MAPK

Molecular and Cellular Biochemistry

Volumn 345, Issue 1-2, 2010, Pages 153-160

  Leshem Lev, D ^a   Hochhauser, E ^b   Chanyshev, B ^a   Isak, A ^a   Shainberg, A ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Adenosine receptor agonists; Cardiac cell cultures; Cardioprotection; Hypoxia; Ischemia; KATP channels; P38 MAPK

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; 2 CHLORO N 6 (3 IODOBENZYL)ADENOSINE 5' N METHYLURONAMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 5 HYDROXYDECANOIC ACID; ADENOSINE A1 RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE TRIPHOSPHATASE (POTASSIUM); ADENOSINE TRIPHOSPHATE; ANISOMYCIN; DIAZOXIDE; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; HEART PROTECTION; HYPOXIA; NONHUMAN; RAT;

ADENOSINE; ADENOSINE A1 RECEPTOR AGONISTS; ADENOSINE A3 RECEPTOR AGONISTS; ANIMALS; ANOXIA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEART; MYOCYTES, CARDIAC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; POTASSIUM CHANNELS; PROTECTIVE AGENTS; RATS;

EID: 78449276676     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0568-5     Document Type: Article

References (43)

1. CE Murry RB Jennings KA Reimer 1986 Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 1124 1136 3769170
2. R Bolli 2007 Preconditioning: a paradigm shift in the biology of myocardial ischemia Am J Physiol 292 H19 H27
3. MV Cohen JM Downey 2009 Adenosine at reperfusion: a conundrum ready to be resolved J Am Coll Cardiol 53 718 719 10.1016/j.jacc.2008.11.016 19232906
4. JA Auchampach X Jin J Moore TC Wan LM Kreckler ZD Ge J Narayanan E Whalley W Kiesman B Ticho G Smits GJ Gross 2004 Comparison of three different A1 adenosine receptor antagonists on infarct size and multiple cycle ischemic preconditioning in anesthetized dogs J Pharmacol Exp Ther 308 846 856 10.1124/jpet.103.057943 14634049
5. ZD Ge JN Peart LM Kreckler TC Wan MA Jacobson GJ Gross JA Auchampach 2006 Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor J Pharmacol Exp Ther 319 1200 1210 10.1124/jpet.106.111351 16985166
6. E Hochhauser O Kaminski H Shalom D Leshem V Shneyvays A Shainberg BA Vidne 2004 Role of adenosine receptor activation in antioxidant enzyme regulation during ischemia-reperfusion in the isolated rat heart Antioxid Redox Signal 6 335 344 10.1089/152308604322899404 15025935
7. GJ Gross 2000 The role of mitochondrial KATP channels in cardioprotection Basic Res Cardiol 95 280 284 10.1007/s003950050004 11005582
8. T Pain XM Yang SD Critz Y Yue A Nakano GS Liu G Heusch MV Cohen JM Downey 2000 Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals Circ Res 87 460 466 10988237
9. Shneyvays V, Leshem D, Mamedova LK, Shainberg A (2003) Activation of adenosine A1 and A3 receptors protects mitochondria during hypoxia in cardiomyocytes by distinct mechanisms. In: Dhalla NS, Takeda N, Singh M, Lukas A (eds) Myocardial ischemia and preconditioning. Kluwer Academic Publishers, Boston, pp 347-364
10. M Barancik P Htun C Strohm S Kilian W Schaper 2000 Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death J Cardiovasc Pharmacol 35 474 483 10.1097/00005344-200003000-00019 10710135
11. R Bassi R Heads MS Marber JE Clark 2008 Targeting p38-MAPK in the ischaemic heart: kill or cure? Curr Opin Pharmacol 8 141 146 10.1016/j.coph.2008.01.002 18289939
12. MA Bogoyevitch J Gillespie-Brown AJ Ketterman SJ Fuller R Ben-Levy A Ashworth CJ Marshall PH Sugden 1996 Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion Circ Res 79 162 173 8755992
13. S Sanada M Kitakaze 2004 Ischemic preconditioning: emerging evidence, controversy, and translational trials Int J Cardiol 97 263 276 10.1016/j.ijcard.2003.12.002 15458694
14. PC Beguin E Belaidi D Godin-Ribuot P Levy C Ribuot 2007 Intermittent hypoxia-induced delayed cardioprotection is mediated by PKC and triggered by p38 MAP kinase and Erk1/2 J Mol Cell Cardiol 42 343 351 10.1016/j.yjmcc.2006.11.008 17188294
15. A Nakano CP Baines SO Kim SL Pelech JM Downey MV Cohen SD Critz 2000 Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK Circ Res 86 144 151 10666409
16. C Ballard-Croft G Kristo Y Yoshimura E Reid BJ Keith RM Mentzer Jr RD Lasley 2005 Acute adenosine preconditioning is mediated by p38 MAPK activation in discrete subcellular compartments Am J Physiol 288 H1359 H1366
17. A Lochner S Genade S Hattingh E Marais B Huisamen JA Moolman 2003 Comparison between ischaemic and anisomycin-induced preconditioning: Role of p38 MAPK Cardiovasc Drugs Ther 17 217 230 10.1023/A:1026116022552 14574080
18. Y Yoshimura G Kristo BJ Keith SA Jahania RM Mentzer Jr RD Lasley 2004 The p38 MAPK inhibitor SB203580 blocks adenosine A(1) receptor-induced attenuation of in vivo myocardial stunning Cardiovasc Drugs Ther 18 433 440 10.1007/s10557-004-6220-4 15770430
19. TC Zhao DS Hines RC Kukreja 2001 Adenosine-induced late preconditioning in mouse hearts: role of p38 MAP kinase and mitochondrial K(ATP) channels Am J Physiol Heart Circ Physiol 280 H1278 H1285 11179074
20. E Hochhauser D Leshem O Kaminski Y Cheporko BA Vidne A Shainberg 2007 The protective effect of prior ischemia reperfusion adenosine A1 or A3 receptor activation in the normal and hypertrophied heart Int Cardiovasc Thorac Surg 6 363 368 10.1510/icvts.2006.136317
21. V Shneyvays D Leshem T Zinman LK Mamedova KA Jacobson A Shainberg 2005 Role of adenosine A1 and A3 receptors in regulation of cardiomyocyte homeostasis following mitochondrial respiratory chain injury Am J Physiol Heart Circ Physiol 288 H2792 H2801 10.1152/ajpheart.01157.2004 15681707
22. A Shainberg S Yitzhaki O Golan KA Jacobson E Hochhauser 2009 Involvement of UTP in protection of cardiomyocytes from hypoxic stress Can J Physiol Pharmacol 87 287 299 10.1139/Y09-010 19370082
23. S Yitzhaki V Shneyvays KA Jacobson A Shainberg 2005 Involvement of uracil nucleotides in protection of cardiomyocytes from hypoxic stress Biochem Pharmacol 69 1215 1223 10.1016/j.bcp.2005.01.018 15794942
24. AL Nieminen GJ Gores JM Bond R Imberti B Herman JJ Lemasters 1992 A novel cytotoxicity screening assay using a multiwell fluorescence scanner Toxicol Appl Pharmacol 115 147 155 10.1016/0041-008X(92)90317-L 1641848
25. N Maulik M Watanabe YL Zu CK Huang GA Cordis JA Schley DK Das 1996 Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts FEBS Lett 396 233 237 10.1016/0014-5793(96)01109-X 8914993
26. JP Headrick L Willems KJ Ashton K Holmgren J Peart GP Matherne 2003 Ischaemic tolerance in aged mouse myocardium: the role of adenosine and effects of A1 adenosine receptor overexpression J Physiol 549 823 833 10.1113/jphysiol.2003.041541 12717009
27. MV Cohen JM Downey 2008 Adenosine: trigger and mediator of cardioprotection Basic Res Cardiol 103 203 215 10.1007/s00395-007-0687-7 17999026
28. TC Wan ZD Ge A Tampo Y Mio MW Bienengraeber WR Tracey GJ Gross WM Kwok JA Auchampach 2008 The A3 adenosine receptor agonist CP-532, 903 [N6-(2, 5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel J Pharmacol Exp Ther 324 234 243 10.1124/jpet.107.127480 17906066
29. R Carroll DM Yellon 2000 Delayed cardioprotection in a human cardiomyocyte-derived cell line: the role of adenosine, p38MAP kinase and mitochondrial KATP Basic Res Cardiol 95 243 249 10.1007/s003950050187 10879626
30. N Nagy K Shiroto G Malik CK Huang M Gaestel M Abdellatif A Tosaki N Maulik DK Das 2007 Ischemic preconditioning involves dual cardio-protective axes with p38MAPK as upstream target J Mol Cell Cardiol 42 981 990 10.1016/j.yjmcc.2007.02.010 17397860
31. P Ping E Murphy 2000 Role of p38 mitogen-activated protein kinases in preconditioning: a detrimental factor or a protective kinase? Circ Res 86 921 922 10807861
32. N Maulik T Yoshida YL Zu M Sato A Banerjee DK Das 1998 Ischemic preconditioning triggers tyrosine kinase signaling: a potential role for MAPKAP kinase 2 Am J Physiol 275 H1857 H1864 9815094
33. K Mubagwa W Flameng 2001 Adenosine, adenosine receptors and myocardial protection: an updated overview Cardiovasc Res 52 25 39 10.1016/S0008-6363(01) 00358-3 11557231
34. Y Zhang EW Gu J Zhang ZW Chen 2007 Role of p38 mitogen-activated protein kinases in cardioprotection of morphine preconditioning Chin. Med. J. (Engl.) 120 777 781
35. C Weinbrenner GS Liu MV Cohen JM Downey 1997 Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart J Mol Cell Cardiol 29 2389 2391 10.1006/jmcc.1997.0473
36. XL Ma S Kumar F Gao CS Louden BL Lopez TA Christopher C Wang JC Lee GZ Feuerstein TL Yue 1999 Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion Circulation 99 1685 1691 10190877
37. K Mackay D Mochly-Rosen 1999 An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia J Biol Chem 274 6272 6279 10.1074/jbc.274.10.6272 10037715
38. HY Sun NP Wang M Halkos F Kerendi H Kin RA Guyton J Vinten-Johansen ZQ Zhao 2006 Postconditioning attenuates cardiomyocyte apoptosis via inhibition of JNK and p38 mitogen-activated protein kinase signaling pathways Apoptosis 11 1583 1593 10.1007/s10495-006-9037-8 16820962
39. DM Yellon JM Downey 2003 Preconditioning the myocardium: from cellular physiology to clinical cardiology Physiol Rev 83 1113 1151 14506302
40. M Loubani M Galinanes 2002 Pharmacological and ischemic preconditioning of the human myocardium: mitoK(ATP) channels are upstream and p38MAPK is downstream of PKC BMC Physiol 2 10 10.1186/1472-6793-2-10 12123527
41. M Loubani A Hassouna M Galinanes 2004 Delayed preconditioning of the human myocardium: signal transduction and clinical implications Cardiovasc Res 61 600 609 10.1016/j.cardiores.2003.10.013 14962490
42. M Kudo Y Wang M Xu A Ayub M Ashraf 2002 Adenosine A(1) receptor mediates late preconditioning via activation of PKC-delta signaling pathway Am J Physiol 283 H296 H301
43. V Shneyvays T Zinman A Shainberg 2004 Analysis of calcium responses mediated by the A(3) adenosine receptor in cultured newborn rat cardiac myocytes Cell Calcium 36 387 396 10.1016/j.ceca.2004.03.004 15451622